UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dementia is an age‐independent risk factor for severity and death in COVID‐19 inpatients

Alzheimer's & dementia, 2021-11, Vol.17 (11), p.1818-1831

2021

Volltextzugriff (PDF)

Structural and morphological characterization of hemozoin produced by Schistosoma mansoni and Rhodnius prolixus

FEBS letters, 2005-11, Vol.579 (27), p.6010-6016

2005

Volltextzugriff (PDF)

Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

Alzheimer's & dementia, 2014-02, Vol.10 (1), p.S76-S83

2014

Volltextzugriff (PDF)

How does brain insulin resistance develop in Alzheimer's disease?

Alzheimer's & dementia, 2014-02, Vol.10 (1), p.S26-S32

2014

Volltextzugriff (PDF)

Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease

Journal of neurochemistry, 2013-07, Vol.126 (2), p.191-202

2013

Volltextzugriff (PDF)

Type I Hsp40s/DnaJs aggregates exhibit features reminiscent of amyloidogenic structures

The FEBS journal, 2024-09, Vol.291 (17), p.3904-3923

2024

Volltextzugriff (PDF)

Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by amyloid‐β (Aβ) oligomers

British journal of pharmacology, 2024-10, Vol.181 (20), p.4028-4049

2024

Volltextzugriff (PDF)

Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia

Alzheimer's & dementia, 2023-06, Vol.19 (6), p.2595-2604

2023

Volltextzugriff (PDF)

Brain insulin, insulin‐like growth factor 1 and glucagon‐like peptide 1 signalling in Alzheimer’s disease

Journal of neuroendocrinology, 2021-04, Vol.33 (4), p.e12959-n/a

Ferreira, Sergio T.

2021

Volltextzugriff (PDF)

Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

IUBMB life, 2007, Vol.59 (4‐5), p.332-345

2007

Volltextzugriff (PDF)

Alzheimer‐associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation

EMBO molecular medicine, 2015-02, Vol.7 (2), p.190-210

2015

Volltextzugriff (PDF)

Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2020, Vol.12 (1), p.n/a

2020

Volltextzugriff (PDF)

Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders

The FASEB journal, 2004-03, Vol.18 (3), p.511-518

2004

Volltextzugriff (PDF)

Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization

The FASEB journal, 2004-09, Vol.18 (12), p.1366-1372

2004

Volltextzugriff (PDF)

Soluble oligomers from a non-disease related protein mimic Aβ-induced tau hyperphosphorylation and neurodegeneration

Journal of neurochemistry, 2007-10, Vol.103 (2), p.736-748

2007

Volltextzugriff (PDF)

Amyloid‐beta oligomers increase the localization of prion protein at the cell surface

Journal of neurochemistry, 2011-05, Vol.117 (3), p.538-553

2011

Volltextzugriff (PDF)

Amyloid‐β oligomers in cellular models of Alzheimer’s disease

Journal of neurochemistry, 2020-11, Vol.155 (4), p.348-369

2020

Volltextzugriff (PDF)

Protein kinase C activity regulates d‐serine availability in the brain

Journal of neurochemistry, 2011-01, Vol.116 (2), p.281-290

2011

Volltextzugriff (PDF)

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease

The Journal of pathology, 2018-05, Vol.245 (1), p.85-100

2018

Volltextzugriff (PDF)

Novel neuroprotective, neuritogenic and anti‐amyloidogenic properties of 2,4‐dinitrophenol: The gentle face of Janus

IUBMB life, 2006-04, Vol.58 (4), p.185-191

2006

Volltextzugriff (PDF)

Formation of amyloid aggregates from human lysozyme and its disease‐associated variants using hydrostatic pressure

The FASEB journal, 2004-07, Vol.18 (10), p.1099-1101

2004

Volltextzugriff (PDF)

Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer’s diseases

Journal of neurochemistry, 2021-02, Vol.156 (4), p.539-552

2021

Volltextzugriff (PDF)

Protein dynamics, folding and misfolding: from basic physical chemistry to human conformational diseases

FEBS letters, 2001-06, Vol.498 (2), p.129-134

2001

Volltextzugriff (PDF)

N-Methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers

Journal of neurochemistry, 2010-12, Vol.115 (6), p.1520-1529

2010

Volltextzugriff (PDF)

Neuritogenesis and neuronal differentiation promoted by 2,4‐dinitrophenol, a novel anti‐amyloidogenic compound

The FASEB journal, 2005-10, Vol.19 (12), p.1627-1636

2005

Volltextzugriff (PDF)

1 – 25 von 466

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals Frontfile Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(453)
Mit Volltextzugriff
(452)

Publikationsform

Sprache

Englisch
(466)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Dementia is an age‐independent risk factor for severity and death in COVID‐19 inpatients

Structural and morphological characterization of hemozoin produced by Schistosoma mansoni and Rhodnius prolixus

Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

How does brain insulin resistance develop in Alzheimer's disease?

Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease

Type I Hsp40s/DnaJs aggregates exhibit features reminiscent of amyloidogenic structures

Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by amyloid‐β (Aβ) oligomers

Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia

Brain insulin, insulin‐like growth factor 1 and glucagon‐like peptide 1 signalling in Alzheimer’s disease

Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

Alzheimer‐associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation

Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease

Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders

Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization

Soluble oligomers from a non-disease related protein mimic Aβ-induced tau hyperphosphorylation and neurodegeneration

Amyloid‐beta oligomers increase the localization of prion protein at the cell surface

Amyloid‐β oligomers in cellular models of Alzheimer’s disease

Protein kinase C activity regulates d‐serine availability in the brain

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease

Novel neuroprotective, neuritogenic and anti‐amyloidogenic properties of 2,4‐dinitrophenol: The gentle face of Janus

Formation of amyloid aggregates from human lysozyme and its disease‐associated variants using hydrostatic pressure

Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer’s diseases

Protein dynamics, folding and misfolding: from basic physical chemistry to human conformational diseases

N-Methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers

Neuritogenesis and neuronal differentiation promoted by 2,4‐dinitrophenol, a novel anti‐amyloidogenic compound

Aktive Filter

Suchergebnisse filtern